Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473833 · ClinicalTrials.gov registry record · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
A NA study of Ovarian Cancer, sponsored by John R van Nagell.
- Recruiting
- Registry status
- NA
- Development phase
- 65,000
- Enrollment target
- 1
- Study location
NCT04473833 is a NA study of Ovarian Cancer that is actively recruiting participants, run by John R van Nagell. The registered enrollment target is 65,000 participants, above the 527-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (12234% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04473833, a NA study of Ovarian Cancer, is actively recruiting participants, sponsored by John R van Nagell.
- RECRUITING
- Registry status
- NA
- Development phase
- 65,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a large, prospective, single-arm cohort study of transvaginal ultrasonographic screening for ovarian cancer in intermediate to high-risk women from Kentucky. Detection of ovarian malignancy often occurs subsequent to the initial transvaginal sonography (TVS) screen; therefore, it is important to offer continued screening to study participants based on our published algorithm. Screening will be available to participants for as long as they elect to receive it. The primary study endpoints are to determine if prospective serial transvaginal ultrasonography can decrease the false-positive (FP) percentage and improve the positive predictive value (PPV) as suggested by retrospective analysis without compromising the detection of true positives or promote the occurrence of false negatives.
Conditions Studied
Interventions
- PROCEDURE Serial Transvaginal Ultrasonography
Study Locations (1)
Kentucky
- Markey Cancer Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65,000 participants |
| Start Date | 1988-12-19 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04473833
The ClinicalTrials.gov registry entry for NCT04473833 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 527-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (12234% higher). The listed sponsor is John R van Nagell, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Serial Transvaginal Ultrasonography is the first listed.
NCT04473833 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04473833 about?
NCT04473833 is a clinical study titled "Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer". This is a large, prospective, single-arm cohort study of transvaginal ultrasonographic screening for ovarian cancer in intermediate to high-risk women from Kentucky. Detection of ovarian malignancy often occurs subsequent to the initial transvaginal sonography (TVS) screen; therefore, it is importan...
What is the current status of trial NCT04473833?
This trial is currently recruiting. It is a NA study. The enrollment target is 65,000 participants. The study started on 1988-12-19. Estimated completion is 2026-12-31.
What conditions does trial NCT04473833 study?
This clinical trial studies the following conditions: Ovarian Cancer.
What interventions are being tested in trial NCT04473833?
The interventions under investigation include: Serial Transvaginal Ultrasonography (PROCEDURE).
Who is sponsoring clinical trial NCT04473833?
This trial is sponsored by John R van Nagell, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04473833 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.